Gemzar Injection 200 mg/5.26 ml contains Gemcitabine. It is a cytotoxic anticancer medication used in hospital and oncology settings under the supervision of qualified healthcare professionals. Gemzar is widely prescribed as part of chemotherapy regimens for several types of solid tumors.
This lower-strength vial is typically used when individualized dosing is required based on the patient’s body surface area and treatment protocol.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Composition
Each vial contains:
-
Gemcitabine 200 mg in 5.26 ml solution
For intravenous (IV) infusion only.
Mechanism of Action
Gemcitabine belongs to the class of antimetabolite agents and works by interfering with DNA synthesis:
-
It is incorporated into the DNA of rapidly dividing cells
-
Causes premature termination of DNA chain elongation
-
Inhibits enzymes required for DNA replication
-
Blocks cell division in the S-phase of the cell cycle
-
Ultimately leads to programmed cell death (apoptosis)
Since cancer cells divide rapidly, they are more vulnerable to gemcitabine compared to normal cells.
Indications
Gemzar Injection is indicated for the treatment of:
-
Non-Small Cell Lung Cancer
-
Pancreatic Cancer
-
Bladder Cancer
-
Breast cancer (in combination therapy)
-
Ovarian cancer (as part of multi-drug chemotherapy regimens)
Dosage and Administration
-
Administered intravenously by trained healthcare professionals only
-
Dose is calculated based on body surface area, clinical condition, and treatment plan
-
Given in cycles, allowing recovery periods between doses
-
Patients require close monitoring during infusion and throughout therapy
Benefits
Gemzar Injection offers several therapeutic advantages:
-
Effective inhibition of tumor cell growth and spread
-
Applicable in multiple types of solid tumors
-
Can be combined with other chemotherapy drugs for enhanced effect
-
Helps improve survival and disease control in certain cancers
-
Flexible dosing for individualized treatment
Possible Side Effects
Like most chemotherapy drugs, gemcitabine can cause side effects:
Common side effects
-
Nausea and vomiting
-
Fatigue and weakness
-
Fever or flu-like symptoms
-
Loss of appetite
Less common side effects
-
Low white blood cell count (leukopenia)
-
Low platelet count (thrombocytopenia)
-
Liver enzyme abnormalities
Serious side effects
-
Myelosuppression
-
Severe infections due to decreased immunity
-
Lung inflammation (interstitial pneumonitis)
-
Kidney or liver dysfunction
Precautions
-
Use only under oncologist supervision
-
Regular blood tests are essential during treatment
-
Caution in patients with kidney, liver, or bone marrow disorders
-
Avoid during pregnancy and breastfeeding
-
Report symptoms like fever, bleeding, or breathing difficulty immediately
Drug Interactions
Gemcitabine may interact with:
-
Other cytotoxic chemotherapy drugs
-
Radiation therapy (may increase side effects)
-
Medications that suppress bone marrow
Storage
-
Store at controlled room temperature as directed
-
Protect from light
-
Do not freeze
-
Use only as prepared by healthcare professionals